Home7AL0 • FRA
add
Alligator Bioscience AB
Previous close
€0.56
Year range
€0.32 - €0.62
Market cap
223.96M SEK
Avg Volume
606.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 319.00K | -95.47% |
Operating expense | 18.22M | -24.26% |
Net income | -8.35M | 86.70% |
Net profit margin | -2.62K | -193.55% |
Earnings per share | — | — |
EBITDA | -43.72M | 23.98% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.85M | -27.91% |
Total assets | 68.80M | -21.62% |
Total liabilities | 167.88M | 21.07% |
Total equity | -99.08M | — |
Shares outstanding | 16.91M | — |
Price to book | -0.10 | — |
Return on assets | -129.51% | — |
Return on capital | 155.46% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.35M | 86.70% |
Cash from operations | -56.80M | 31.40% |
Cash from investing | 2.21M | — |
Cash from financing | 19.94M | -64.78% |
Net change in cash | -35.46M | -35.87% |
Free cash flow | -102.67M | -11,392.19% |
About
Founded
2000
Website
Employees
33
